Clinical Trial Update: Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial is evaluating phytocannabinoids for reducing chemotherapy-induced peripheral neuropathy in breast and colon cancer survivors; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colon Cancer

Drugs mentioned

• Phytocannabinoids (phytocannabinoids)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy | Phase 2 | Status: RECRUITING